The preventive effect of Mangifera foetida L. leaf extract administered simultaneously to excess iron on markers of iron overload in Spraque-Dawley rats
Abstract
Background: Recently, there is no agent available for the prevention of iron overload (IO) in thalassemia patients. Previous studies showed that Mangifera foetida L. leaf extracts reduced the levels of iron in IO in vitro and in vivo models. The present study aimed to determine the efficacy of Mangifera foetida L. leaf extract in the prevention of IO induced in rats.
Methods: Thirty male Sprague-Dawley rats were divided into 5 groups: control (untreated), IO, 3 treatment groups with leaf extract equivalent to 50, 100, and 200 mg of mangiferin per kg BW. Fe-dextran (15 mg) was administered intraperitoneally twice a week for 4 weeks to all groups except control (IO, DSM50, DSM100, and DSM200). Urine and blood samples were taken before and after treatments. After 4 weeks of treatment, rats were terminated, and samples of spleen, liver, and heart were taken. Ferritin and mangiferin levels and SOD activities were determined in plasma. Iron levels were measured in plasma, urine, and spleen.
Results: Experimental IO increased plasma Fe content 4.23 times and plasma ferritin levels 6.9 times vs normal. Mangifera foetida L. leaf extract DSM50 resulted in the highest blood levels of 212 ng mangiferin per mL and moderately, although not significant, prevented increased plasma ferritin levels and IO in organs and protected against oxidative stress.
Conclusion: Aqueous Mangifera foetida L. leaf extract may be useful to prevent IO and oxidative stress in thalassemia patients.
References
Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med. 2012;366(4):348–59. https://doi.org/10.1056/NEJMra1004967
Olivieri NF. The β-Thalassemias. N Engl J Med. 1999;341(2):99–109. https://doi.org/10.1056/NEJM199907083410207
Depkes. Riset kesehatan dasar 2007. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2008. Indonesian.
Aster JC. Hematopoietic and lymphoid systems. In: Kumar V, Abbas AK, Aster JC, eds. Robins Basic Pathology. 9th ed. Philadelphia: Elsevier. 2013:413–6.
Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–46. https://doi.org/10.1056/NEJMra050436
Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys. 2009;53(2):75–100. https://doi.org/10.1007/s12013-009-9043-x
Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011;364(2):146–56. https://doi.org/10.1056/NEJMct1004810
Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K, et al. New antidiabetic compounds mangiferin and its glucoside. Biol Pharm Bull. 1998;21(12):1389–90. https://doi.org/10.1248/bpb.21.1389
Wang RR, Gao YD, Ma CH, Zhang XJ, Huang GC, Huang JF, et al. Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains. Molecules. 2011;16(5):4264–77. https://doi.org/10.3390/molecules16054264
Yoshimi N, Matsunaga K, Katayama M, Yamada Y, Kuno T, Qiao Z, et al. The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats. Cancer Lett. 2001;163(2):163–70. https://doi.org/10.1016/S0304-3835(00)00678-9
Leiro J, Arranz JA, Yáñez M, Ubeira FM, Sanmartın ML, Orallo F. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int Immunopharmacol. 2004;4:763–78. https://doi.org/10.1016/j.intimp.2004.03.002
Pardo-Andreu GL, Barrios MF, Curti C, Hernández I, Merino N, Lemus Y, et al. Protective effects of Mangifera indica L extract (Vimang), and its major component mangiferin, on iron-induced oxidative damage to rat serum and liver. Pharmacol Res. 2008;57(1):79–86. https://doi.org/10.1016/j.phrs.2007.12.004
Wahyuni T. Pengaruh mangiferin dan ekstrak air daun Mangifera foetida L sebagai zat pengkelat besi dan antioksidan secara in vivo pada tikus Sprague Dawley. Tesis Fakultas Kedokteran Universitas Indonesia. 2013. Indonesian.
Hou S, Wang F, Li Y, Li Y, Wang M, Sun D, et al. Pharmacokinetic study of mangiferin in human plasma after oral administration. Food Chem. 2012;132(1):289–94. https://doi.org/10.1016/j.foodchem.2011.10.079
Papanastasiou DA, Vayenas D V, Vassilopoulos A, Repanti M. Animal and in vitro models in human disease concentration of iron and distribution of iron and transferrin after experimental iron overload in rat tissues in vivo: study of the liver, the spleen, the central nervous system and other organs. Pathol Res Pract. 2000;196(1):47–54. https://doi.org/10.1016/S0344-0338(00)80021-7
Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170–517.
Pardo-Andreu GL, Delgado R, Núñez-Sellés AJ, Vercesi AE, Gilberto L. Dual mechanism of mangiferin protection against iron-induced damage to 2-deoxyribose and ascorbate oxidation. Pharmacol Res. 2006;53(3):253–60. https://doi.org/10.1016/j.phrs.2005.06.006
Kim W-J, Veriansyah B, Lee Y-W, Kim J, Kim J-D. Extraction of mangiferin from Mahkota Dewa (Phaleria macrocarpa) using subcritical water. J Ind Eng Chem. 2010;16(3):425–30. https://doi.org/10.1016/j.jiec.2009.08.008
Ma H, Chen H, Sun L, Tong L, Zhang T. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014;93:54–61. https://doi.org/10.1016/j.fitote.2013.10.016
Porter JB. Practical management of iron overload. Br J Haematol. 2001;115(2):239–52. https://doi.org/10.1046/j.1365-2141.2001.03195.x
Pohan APN, Purwaningsih EH, Dwijayanti A. Efek kelasi ekstrak etanol daun Mangifera foetida pada feritin serum penderita talasemia di RS Cipto Mangunkusumo, Tahun 2012. eJKI. 2013;1(1):45–52. Indonesian.
Li Y. Antioxidants in biology and medicine. New York: Nova Science Publishers; 2011.
Fuchs J, Freisleben H-J, Packer L. Antioxidants in the skin. In: Mukhtar H, ed. Pharmacology of the Skin. Boca Raton: CRC Press; 1991. p. 249–67.
McCord JM. Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves. Dose Response. 2008;6(3):223–38. https://doi.org/10.2203/dose-response.08-012.McCord
Pardo-Andreu GL, Cavalheiro RA, Dorta DJ, Naal Z, Vercesi E, Curti C. Fe (III) shifts the mitochondria permeability transition-eliciting capacity of mangiferin to protection of organelle. J Pharmacol Exp Ther. 2007;320(2):646–53. https://doi.org/10.1124/jpet.106.112003
Copyright (c) 2018 Purnama Fajri, Ari Estuningtyas, Melva Louisa, Hans-Joachim Freisleben
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
